Biomarin Pharmaceutical Inc. (BMRN) on GreekSoup https://greeksoup.ai/stocks/us/bmrn/ Every dated entry in the public record on Biomarin Pharmaceutical Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Biomarin Pharmaceutical Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-10-06:ac1ad31a01Tue, 06 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: material agreementhttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-09-30:21173a2aafWed, 30 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-09-15:1edc5a89aaTue, 15 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: short interest 10,075,655 shares at the 15 September 2026 settlement, 5.53 days to coverhttps://greeksoup.ai/stocks/us/bmrn/short-interest/us:BMRN:short-interest:2026-09-15:1e3d178ca0Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-09-14:21c111ea0aMon, 14 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: Davis George Eric (EVP, Chief Legal Officer) sold 17,557 shares at $66.28 on 2 September 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/bmrn/insiders/us:BMRN:insider:2026-09-03:7e61a3e3cbThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: Form 144, Davis George Eric plans to sell 17,557 shares worth $1.2 million around 2 September 2026https://greeksoup.ai/stocks/us/bmrn/planned-sales/us:BMRN:planned-sale:2026-09-02:c4fcee72dfWed, 02 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-09-01:0781fb13f3Tue, 01 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-08-31:9584786342Mon, 31 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: short interest 9,877,553 shares at the 31 August 2026 settlement, 5.76 days to coverhttps://greeksoup.ai/stocks/us/bmrn/short-interest/us:BMRN:short-interest:2026-08-31:3deb52f074Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: material agreement, regulation fd disclosurehttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-08-18:75ae8d8c77Tue, 18 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: short interest 10,202,950 shares at the 14 August 2026 settlement, 3.69 days to coverhttps://greeksoup.ai/stocks/us/bmrn/short-interest/us:BMRN:short-interest:2026-08-14:2492a298c9Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. Q2 FY2026 results: revenue $990 million, net income $45 millionhttps://greeksoup.ai/stocks/us/bmrn/results/fy2026-q2/us:BMRN:result:2026-08-06:2aba01e2c0Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-08-06:6892147bd8Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-08-06:4dccf8172dThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-08-06:2fd2863972Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: short interest 12,504,131 shares at the 31 July 2026 settlement, 7.42 days to coverhttps://greeksoup.ai/stocks/us/bmrn/short-interest/us:BMRN:short-interest:2026-07-31:014dc82833Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc.: short interest 14,315,984 shares at the 15 July 2026 settlement, 10.16 days to coverhttps://greeksoup.ai/stocks/us/bmrn/short-interest/us:BMRN:short-interest:2026-07-15:3d4858d0bdWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Biomarin Pharmaceutical Inc. filed 8-K/A: other eventshttps://greeksoup.ai/stocks/us/bmrn/filings/us:BMRN:filing:2026-07-13:d44b4dc5adMon, 13 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>